AIC
HQL

Archer Investment Corporation’s abrdn Life Sciences Investors HQL Stock Holding History

Archer Investment Corporation’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-345
Closed -$6.8K – 606
2021
Q1 		$6.8K Sell
345
-1,129
-77% -$23.3K ﹤0.01% 567
2020
Q4 		$29.1K Buy
+1,474
New +$27.2K 0.01% 381
2020
Q3 		– Sell
-3,160
Closed -$56.8K – 664
2020
Q2 		$56.8K Buy
3,160
+1,474
+87% +$25.3K 0.03% 234
2020
Q1 		$25K Buy
+1,686
New +$27.6K 0.02% 323

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Archer Investment Corporation's HQL Position: Q2 2021 in Review

Archer Investment Corporation sold out of abrdn Life Sciences Investors (HQL) in Q2 2021, closing a stake of 345 shares — an estimated $6.8K sold.

Archer Investment Corporation first reported a position in HQL in Q1 2020 and held it in 4 quarters. The position peaked at $56.8K in Q2 2020. 67 funds tracked by Wall St. Rank hold HQL as of Q2 2021.

  • Archer Investment Corporation reported no remaining abrdn Life Sciences Investors position as of Q2 2021 after selling out during the quarter.
  • Archer Investment Corporation sold 345 abrdn Life Sciences Investors shares in Q2 2021, an estimated $6.8K.
  • Archer Investment Corporation first reported a position in abrdn Life Sciences Investors in Q1 2020 and held it in 4 quarters.
  • Archer Investment Corporation's abrdn Life Sciences Investors position peaked at $56.8K in Q2 2020.
  • 67 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2021.

Based on Archer Investment Corporation's 13F filing for Q2 2021, filed 5 Aug 2021.